The purpose of this clinical study is to assess the safety, extent and route of [3H]
BMS747158 radioactivity eliminated (mass balance) in urine and feces of healthy male
subjects. The safety of [3H] BMS747158 administration will also be assessed, as well as
pharmacokinetics of [3H] BMS747158 and metabolite identification.